Compare MiniMed Group Inc. Common Stock (MMED) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MiniMed Group Inc. Common Stock vs Ralph Lauren Corp — how do they compare? MiniMed Group Inc. Common Stock trades at $19.57 (market cap $5.57B), while Ralph Lauren Corp trades at $369.75 (market cap $21.89B). The key difference: Ralph Lauren Corp is far larger — about 3.9× MiniMed Group Inc. Common Stock's market cap, and Ralph Lauren Corp pays a 1.09% dividend while MiniMed Group Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 0 Days and Ralph Lauren Corp for 84 Days on average.
| MMED | RL | |
|---|---|---|
Market Cap | $5.57B | $21.89B |
Volume | 23,336,073 | 481,617 |
Sector | Health | Consumer Cyclical |
52-Week High | $23.84 | $414.25 |
52-Week Low | $10.80 | $309.29 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $5.37B | $22.95B |
Dividend Yield | — | 1.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ralph Lauren (RL) trades at $361.14, down 2.04% on the day, amid a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue and net income have grown steadily, reaching $7.08 billion and $743 million in 2025, respectively, while profitability metrics like a 70.27% gross margin and 37.54% ROE highlight operational strength. Analyst sentiment remains bullish with a consensus price target of $456.67, though technical indicators show near-term resistance at $363.
The outlook for RL is positive based on fundamental growth and analyst support, but investors face risks from market volatility and execution challenges. The stock's current valuation at a P/E of 23.15 appears reasonable given earnings momentum, yet competitive pressures and macroeconomic factors could limit upside. Institutional confidence is high, with 66.67% of analysts rating it a buy, suggesting potential for appreciation if the company maintains its earnings trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MiniMed Group Inc. Common Stock
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
